Birchbrook, Inc. Moderna, Inc. Transaction History
Birchbrook, Inc.
- $187 Billion
- Q2 2025
A detailed history of Birchbrook, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Birchbrook, Inc. holds 400 shares of MRNA stock, worth $10,996. This represents 0.01% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$10,996
Previous $11.3 Million
2.68%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
266MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$703 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$607 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$475 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$244 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...